Avid Bioservices Inc expected to post earnings of 4 cents a share - Earnings Preview

Avid Bioservices

06/09/2021 21:00

* Avid Bioservices Inc  CDMO.OQ   CDMO.O  is expected to show a
rise in quarterly revenue when it reports results on September
8. 
* The Tustin, California-based company is expected to report   a
9.5% increase in revenue to $27.808 million from $25.39 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Avid Bioservices Inc is
for earnings of 4 cents per share. For the same quarter last
year, the company reported earnings of 6 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Avid
Bioservices Inc is $28.5​, about 18.9% above​ its last closing
price of $23.12. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Apr. 30 2021  0.00        0.01       -0.04     Missed  -900
 Jan. 31 2021  -0.03       -0.03      0.01      Beat    133.3
 Oct. 31 2020  -0.05       -0.06      0.01      Beat    117.6​
 Jul. 31 2020  -0.07       -0.07      0.06      Beat    180
 Apr.          -0.17​      -0.16      -0.11     Beat    32.7​
 30​ 2020​                                              
 Jan. 31 2020  -0.04       -0.04      -0.06     Missed  -57.9​
 Oct. 31 2019  -0.07       -0.05      -0.03     Beat    42.3
 Jul. 31 2019  -0.03       -0.03      -0.08     Missed  -166.7
 This summary was machine generated September 6 at 20:00 GMT. 
All figures in US dollars unless otherwise stated